Zhejiang Provincial People's Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1978-01-01
- Employees
- -
- Market Cap
- -
SOX-based CRT for Esophageal Cancer.
Phase 1
Withdrawn
- Conditions
- Esophageal Cancer
- Interventions
- First Posted Date
- 2019-06-19
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Registration Number
- NCT03991104
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cancer
Phase 1
Completed
- Conditions
- Pancreatic CarcinomaPancreatic Cancer
- Interventions
- Biological: iNeo-Vac-P01Other: GM-CSF
- First Posted Date
- 2018-08-24
- Last Posted Date
- 2021-11-16
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 7
- Registration Number
- NCT03645148
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer
Phase 2
Terminated
- Conditions
- Neoadjuvant ChemotherapyPancreatic Cancer
- Interventions
- Drug: S1,Drug: Paclitaxel-albumin
- First Posted Date
- 2018-07-12
- Last Posted Date
- 2021-01-08
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT03585062
- Locations
- 🇨🇳
Zhejiang procincial people's hospital, Hanzhou, Zhejiang, China
A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease
Phase 4
- Conditions
- Cognitive FunctionAlzheimer Disease
- Interventions
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2017-05-12
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03151382
S-1 and Radiotherapy for Elderly Esophageal Cancer Patients
Phase 2
Withdrawn
- Conditions
- Esophageal CancerS-1Radiotherapy
- Interventions
- Radiation: radiotherapy
- First Posted Date
- 2016-03-23
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Registration Number
- NCT02716688
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction
- Conditions
- Acute Myocardial InfarctionPercutaneous Coronary InterventionCoronary Artery Disease
- First Posted Date
- 2015-12-29
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 3000
- Registration Number
- NCT02641184
- Locations
- 🇨🇳
Zhejiang provincial people's hospital, Hangzhou, Zhejiang, China
Aspirin on CTCs of Advanced Breast and Colorectal Cancer
- First Posted Date
- 2015-11-11
- Last Posted Date
- 2015-11-13
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT02602938
- Locations
- 🇨🇳
Zhejiang provincial people's hospital, Hangzhou, Zhejiang, China
Abscopal Effect for Metastatic Non-small Cell Lung Cancer.
Phase 2
Withdrawn
- Conditions
- RadiotherapyMetastatic Non-small Cell Lung CancerNon-small Cell Lung CancerThymalfasin
- Interventions
- Radiation: Radiotherapy
- First Posted Date
- 2015-09-07
- Last Posted Date
- 2019-03-26
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Registration Number
- NCT02542930
Abscopal Effect for Metastatic Small Cell Lung Cancer
Phase 2
Withdrawn
- Conditions
- Small Cell Lung CancerRadiotherapyThymalfasin
- Interventions
- Radiation: Radiotherapy
- First Posted Date
- 2015-09-04
- Last Posted Date
- 2019-03-21
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Registration Number
- NCT02542137
Abscopal Effect for Metastatic Colorectal Cancer
Phase 2
Withdrawn
- Conditions
- Colorectal CancerMetastatic Colorectal CancerThymalfasin
- Interventions
- Radiation: Radiation therapy
- First Posted Date
- 2015-08-31
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Registration Number
- NCT02535988
© Copyright 2025. All Rights Reserved by MedPath